Cryptococcus deneoformans is an opportunist yeast pathogen and causative agent of meningoencephalitis in humans. It is known to be mainly distributed in temperate climates. Most of our current understanding of this species has come from clinical isolates, leaving environmental populations largely unexplored. The Middle East remains one such underexplored area with no published study to date investigating cryptococcal diversity in soil. In this study, we identified 76 C. deneoformans isolates from a survey of 562 soil samples collected from six cities in Saudi Arabia. Multilocus sequence typing revealed the presence of two major sequence types (STs), ST160 (n = 63) and ST294 (n = 9), along with four singleton STs, three of which were novel. One novel ST, ST613, was likely a recombinant product between ST160 and ST294. Among the 76 isolates, 75 belonged to mating type (MAT)α while one isolate was MATa. Our analyses suggest that the Saudi Arabian C. deneoformans population likely reproduces both asexually and sexually in nature. Our study is the first to report the occurrence of C. deneoformans in a desert climate, representing a novel expansion to this species' currently known ecological niche.

Download full-text PDF

Source
http://dx.doi.org/10.1093/femsec/fiz122DOI Listing

Publication Analysis

Top Keywords

cryptococcus deneoformans
8
deneoformans population
8
saudi arabian
8
st160 st294
8
deneoformans
5
fantastic yeasts
4
yeasts find
4
find discovery
4
discovery clonal
4
clonal cryptococcus
4

Similar Publications

Distinct evolutionary trajectories following loss of RNA interference in .

Proc Natl Acad Sci U S A

November 2024

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.

Article Synopsis
  • * Researchers identified clinical isolates with hypermutation due to transposition of a retrotransposon (Cnl1), driven by a mutation in an RNA interference (RNAi) component.
  • * A study revealed that while some isolates lose RNAi function without triggering hypermutation, introducing RNAi loss mutations into non-hypermutator strains could induce a hypermutator phenotype, highlighting two possible evolutionary pathways following RNAi loss: either leading to hypermutation or enabling survival without it.
View Article and Find Full Text PDF

State of the Field: Cytotoxic Immune Cell Responses in and Infection.

J Fungi (Basel)

October 2024

Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455, USA.

is an environmental pathogen that causes life-threatening disease in immunocompromised persons. The majority of immunological studies have centered on CD4 T-cell dysfunction and associated cytokine signaling pathways, optimization of phagocytic cell function against fungal cells, and identification of robust antigens for vaccine development. However, a growing body of literature exists regarding cytotoxic cells, specifically CD8 T-cells, Natural Killer cells, gamma/delta T-cells, NK T-cells, and Cytotoxic CD4 T-cells, and their role in the innate and adaptive immune response during and infection.

View Article and Find Full Text PDF

While increased mutation rates typically have negative consequences in multicellular organisms, hypermutation can be advantageous for microbes adapting to the environment. Previously, we identified two hypermutator clinical isolates that rapidly develop drug resistance due to transposition of a retrotransposon, Cnl1. Cnl1-mediated hypermutation is caused by a nonsense mutation in the gene encoding a novel RNAi component, Znf3, combined with a tremendous transposon burden.

View Article and Find Full Text PDF

Unlabelled: Cryptococcosis, caused by fungi of the genus , manifests in a broad range of clinical presentations, including severe pneumonia and disease of the central nervous system (CNS) and other tissues (bone and skin). Immune deficiency or development of overexuberant inflammatory responses can result in increased susceptibility or host damage, respectively, during fungal encounters. Leukotrienes help regulate inflammatory responses against fungal infections.

View Article and Find Full Text PDF

Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β-1,3-Glucanosyltransferases.

Angew Chem Int Ed Engl

August 2024

Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain.

Article Synopsis
  • * Researchers used single-domain nanobodies from camels to target a specific enzyme (β-1,3-glucanosyltransferases) crucial for fungal survival, revealing important structural insights.
  • * The tested nanobody showed strong antifungal effects in laboratory settings and in animal models, particularly against certain strains of C. neoformans, suggesting it could be a promising avenue for developing new antifungal therapies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!